IRIS Accounts Production v26.2.0.496 13130505 director 1.2.25 31.1.26 31.1.26 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh131305052025-01-31131305052026-01-31131305052025-02-012026-01-31131305052024-01-31131305052024-02-012025-01-31131305052025-01-3113130505ns15:EnglandWales2025-02-012026-01-3113130505ns14:PoundSterling2025-02-012026-01-3113130505ns10:Director12025-02-012026-01-3113130505ns10:PrivateLimitedCompanyLtd2025-02-012026-01-3113130505ns10:SmallEntities2025-02-012026-01-3113130505ns10:AuditExempt-NoAccountantsReport2025-02-012026-01-3113130505ns10:SmallCompaniesRegimeForDirectorsReport2025-02-012026-01-3113130505ns10:SmallCompaniesRegimeForAccounts2025-02-012026-01-3113130505ns10:FullAccounts2025-02-012026-01-3113130505ns10:CompanySecretary12025-02-012026-01-3113130505ns10:RegisteredOffice2025-02-012026-01-3113130505ns5:CurrentFinancialInstruments2026-01-3113130505ns5:CurrentFinancialInstruments2025-01-3113130505ns5:ShareCapital2026-01-3113130505ns5:ShareCapital2025-01-3113130505ns5:RetainedEarningsAccumulatedLosses2026-01-3113130505ns5:RetainedEarningsAccumulatedLosses2025-01-3113130505ns5:PlantMachinery2025-02-012026-01-3113130505ns5:MotorVehicles2025-02-012026-01-3113130505ns5:ComputerEquipment2025-02-012026-01-3113130505ns5:PlantMachinery2025-01-3113130505ns5:MotorVehicles2025-01-3113130505ns5:ComputerEquipment2025-01-3113130505ns5:PlantMachinery2026-01-3113130505ns5:MotorVehicles2026-01-3113130505ns5:ComputerEquipment2026-01-3113130505ns5:PlantMachinery2025-01-3113130505ns5:MotorVehicles2025-01-3113130505ns5:ComputerEquipment2025-01-3113130505ns5:WithinOneYearns5:CurrentFinancialInstruments2026-01-3113130505ns5:WithinOneYearns5:CurrentFinancialInstruments2025-01-3113130505ns5:DeferredTaxation2025-01-3113130505ns5:DeferredTaxation2025-02-012026-01-3113130505ns5:DeferredTaxation2026-01-3113130505ns10:Director112025-01-3113130505ns10:Director112024-01-3113130505ns10:Director112025-02-012026-01-3113130505ns10:Director112024-02-012025-01-3113130505ns10:Director112026-01-3113130505ns10:Director112025-01-31
REGISTERED NUMBER: 13130505 (England and Wales)











Financial Statements

for the Year Ended 31 January 2026

for

SANDY FLANN DERMATOLOGY LTD

SANDY FLANN DERMATOLOGY LTD (REGISTERED NUMBER: 13130505)






Contents of the Financial Statements
for the Year Ended 31 January 2026




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


SANDY FLANN DERMATOLOGY LTD

Company Information
for the Year Ended 31 January 2026







DIRECTOR: Dr S Flann





SECRETARY: Mr T I Flann





REGISTERED OFFICE: 42 Lytton Road
Barnet
United Kingdom
EN5 5BY





REGISTERED NUMBER: 13130505 (England and Wales)





ACCOUNTANTS: JLA Accountants
42 Lytton Road
Barnet
Hertfordshire
EN5 5BY

SANDY FLANN DERMATOLOGY LTD (REGISTERED NUMBER: 13130505)

Balance Sheet
31 January 2026

31.1.26 31.1.25
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 43,503 51,475

CURRENT ASSETS
Debtors 5 173,612 275,003
Cash at bank 98,495 44,170
272,107 319,173
CREDITORS
Amounts falling due within one year 6 85,676 83,598
NET CURRENT ASSETS 186,431 235,575
TOTAL ASSETS LESS CURRENT
LIABILITIES

229,934

287,050

PROVISIONS FOR LIABILITIES 7 9,746 11,826
NET ASSETS 220,188 275,224

CAPITAL AND RESERVES
Called up share capital 104 104
Retained earnings 220,084 275,120
SHAREHOLDERS' FUNDS 220,188 275,224

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 January 2026.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 January 2026 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges her responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 21 October 2026 and were signed by:





Dr S Flann - Director


SANDY FLANN DERMATOLOGY LTD (REGISTERED NUMBER: 13130505)

Notes to the Financial Statements
for the Year Ended 31 January 2026

1. STATUTORY INFORMATION

Sandy Flann Dermatology Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery - 20% on Cost
Motor vehicles - 25% on reducing balance
Computer equipment - 20% on reducing balance

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 3 (2025 - 2 ) .

SANDY FLANN DERMATOLOGY LTD (REGISTERED NUMBER: 13130505)

Notes to the Financial Statements - continued
for the Year Ended 31 January 2026

4. TANGIBLE FIXED ASSETS
Plant and Motor Computer
machinery vehicles equipment Totals
£    £    £    £   
COST
At 1 February 2025 1,953 96,094 11,633 109,680
Additions 2,050 - 3,197 5,247
At 31 January 2026 4,003 96,094 14,830 114,927
DEPRECIATION
At 1 February 2025 423 53,427 4,355 58,205
Charge for year 801 10,666 1,752 13,219
At 31 January 2026 1,224 64,093 6,107 71,424
NET BOOK VALUE
At 31 January 2026 2,779 32,001 8,723 43,503
At 31 January 2025 1,530 42,667 7,278 51,475

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.1.26 31.1.25
£    £   
Trade debtors 9,548 15,727
Other debtors 159,454 175,212
Directors' current accounts 4,610 84,064
173,612 275,003

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.1.26 31.1.25
£    £   
Trade creditors - 2,039
Tax 43,562 50,383
Social security and other taxes 455 397
Other creditors 39,500 28,394
Accruals and deferred income 2,159 2,385
85,676 83,598

7. PROVISIONS FOR LIABILITIES
31.1.26 31.1.25
£    £   
Deferred tax 9,746 11,826

Deferred
tax
£   
Balance at 1 February 2025 11,826
Provided during year (2,080 )
Balance at 31 January 2026 9,746

SANDY FLANN DERMATOLOGY LTD (REGISTERED NUMBER: 13130505)

Notes to the Financial Statements - continued
for the Year Ended 31 January 2026

8. DIRECTOR'S ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 31 January 2026 and 31 January 2025:

31.1.26 31.1.25
£    £   
Dr S Flann
Balance outstanding at start of year 84,064 -
Amounts advanced 46,676 84,064
Amounts repaid (126,130 ) -
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 4,610 84,064

As at balance sheet date, included in debtors due within one year is £4,610 (2025 : £84,064) due from the directors. During the period interest of £850 was charged at 2.25% on the outstanding balance up to 05/04/2025 and at 3.75% thereafter. The amount was fully repaid within 9 months of the balance sheet date.

9. RELATED PARTY DISCLOSURES

As of the balance sheet date, included in debtors due within one year is £159,454 (2025: £159,454) due and payable by Pennard Practice Limited.The amount is interest-free and repayable upon demand

10. ULTIMATE CONTROLLING PARTY

The ultimate controlling party is Dr S Flann.